PUBLIC CONTRACT · 2018
61048318-AQ. Urgente Valganciclovir 450 mg, Ruxolitinib 20mg
- Contract value
- €12,753.65
- Signed on
- 5 November 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5879352PUBLISHED SUBJECT
61048318-AQ. Urgente Valganciclovir 450 mg, Ruxolitinib 20mg
WHO CONTRACTED
Parties involved
- Awardee
- TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA; - - NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA
- Place of performance
- Portugal, Setúbal, Setúbal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
- Awardee
- - - NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €12,753.65
- Procedure base price
- €12,753.65
- Total effective price
- Not reported on Portal BASE
- Publication date
- 27 September 2019
- Award date
- 5 November 2018
- Signing date
- 5 November 2018
- Performance period
- 15 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Medicamentos antivíricos e antifúngicos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4186054
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.